Vmbook Online ordering

Drug Related Products

Pcyn (Psychemedics Corporation) is a company that operates in the healthcare sector, specifically in the area of drug testing. The company uses hair samples to perform drug testing for companies, government agencies, and other organizations. The stock is listed on the NASDAQ stock exchange.

When it comes to financials, Psychemedics Corporation reported a net income of $1.5 million for the quarter ended September 30, 2021, compared to a net income of $1.2 million for the same quarter in the previous year. This represents an increase of 22.2% in net income year-over-year. The company's earnings per share (EPS) for the quarter were $0.15, compared to $0.12 for the same quarter in the previous year.

In terms of growth, Psychemedics Corporation has seen a steady increase in revenue over the past few years, with revenue for the first nine months of 2021 reaching $25.5 million, compared to $24.3 million for the same period in 2020. This represents an increase of 4.9% in revenue year-over-year.

It is worth mentioning that, as a small cap company, the company's stock is considered to be more volatile and risky compared to larger, established companies. Furthermore, like any other company, Psychemedics Corporation's stock price and financial performance can be influenced by a variety of factors, including, but not limited to, changes in the economy, the company's financial performance, regulatory changes, and industry trends.

As always, before making any investment decisions, it is recommended to conduct your own research and consult with a financial advisor. Also, it is important to keep in mind that the past performance of a stock does not necessarily predict its future performance and that investing in the stock market always carries risk.